On October 31, 2019 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported it will host a conference call with management to discuss the third quarter 2019 financial results, provide an update on the company’s business, and discuss expectations for the future on Thursday, November 7, 2019 at 4:30 p.m. Eastern/1:30 p.m. Pacific (Press release, Spectrum Pharmaceuticals, OCT 31, 2019, View Source [SID1234550098]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call:

Thursday, November 7, 2019 @ 4:30 p.m. Eastern/1:30 p.m. Pacific

Domestic:

(877) 837-3910, Conference ID# 1469173

International:

(973) 796-5077, Conference ID# 1469173

For interested individuals unable to join the call, a replay will be available from November 7, 2019 @ 7:30 p.m. ET/4:30 p.m. PT through November 14, 2019 until 11:59 p.m. ET/8:59 p.m. PT.

Domestic Replay Dial-In #:

(855) 859-2056, Conference ID# 1469173

International Replay Dial-In #:

(404) 537-3406, Conference ID# 1469173

This conference call will also be webcast. Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals’ website: View Source on November 7, 2019 at 4:30 p.m. Eastern/1:30 p.m. Pacific.